Lymphocyte Function Alteration [PE] - N0000178327
Pharmacologic Class Information
| Pharmacologic Code | N0000178327 |
| Pharmacologic Name | Lymphocyte Function Alteration |
| Pharmacologic Uses |
|
| Pharmacologic Concept | Physiologic Effects - [PE] |
| Pharmacologic Concept Description | This concept refers to the tissue, organ, or organ system effects of drug generic ingredients, organized into an organ system classification hierarchy, beneath the "Physiological Effects [PE]" concept. |
NDC Products with Lymphocyte Function Alteration
The table contains 3 products whose active ingredient are classified under the same pharmacologic class Lymphocyte Function Alteration [PE].
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 0009-7224 | Atgam | Non-Proprietary Name: Equine Thymocyte Immune Globulin | Injection, Solution | Intravenous | Pharmacia & Upjohn Company Llc | ACTIVE | |
| 48951-6080 | Lymphocytes 6x | Non-Proprietary Name: Lymphocytes 6x | Liquid | Oral | Uriel Pharmacy Inc. | ACTIVE | |
| 58468-0080 | Thymoglobulin | Non-Proprietary Name: Anti-thymocyte Globulin (rabbit) | Injection, Powder, Lyophilized, For Solution | Intravenous | Genzyme Corporation | ACTIVE |
